Changes in myofilament proteins, but not Ca²⁺ regulation, are associated with a high-fat diet-induced improvement in contractile function in heart failure
Pathological conditions such as diabetes, insulin resistance, and obesity are characterized by elevated plasma and myocardial lipid levels and have been reported to exacerbate the progression of heart failure (HF). Alterations in cardiomyocyte Ca(2+) regulatory properties and myofilament proteins ha...
Saved in:
Published in: | American journal of physiology. Heart and circulatory physiology Vol. 301; no. 4; p. H1438 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
01-10-2011
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Pathological conditions such as diabetes, insulin resistance, and obesity are characterized by elevated plasma and myocardial lipid levels and have been reported to exacerbate the progression of heart failure (HF). Alterations in cardiomyocyte Ca(2+) regulatory properties and myofilament proteins have also been implicated in contractile dysfunction in HF. However, our prior studies reported that high saturated fat (SAT) feeding improves in vivo myocardial contractile function, thereby exerting a cardioprotective effect in HF. Therefore, we hypothesized that SAT feeding improves contractile function by altering Ca(2+) regulatory properties and myofilament protein expression in HF. Male Wistar rats underwent coronary artery ligation (HF) or sham surgery (SH) and were fed normal chow (SHNC and HFNC groups) or a SAT diet (SHSAT and HFSAT groups) for 8 wk. Contractile properties were measured in vivo [echocardiography and left ventricular (LV) cannulation] and in isolated LV cardiomyocytes. In vivo measures of contractility (peak LV +dP/dt and -dP/dt) were depressed in the HFNC versus SHNC group but improved in the HFSAT group. Isolated cardiomyocytes from both HF groups were hypertrophied and had decreased percent cell shortening and a prolonged time to half-decay of the Ca(2+) transient versus the SH group; however, SAT feeding reduced in vivo myocyte hypertrophy in the HFSAT group only. The peak velocity of cell shortening was reduced in the HFNC group but not the HFSAT group and was positively correlated with in vivo contractile function (peak LV +dP/dt). The HFNC group demonstrated a myosin heavy chain (MHC) isoform switch from fast MHC-α to slow MHC-β, which was prevented in the HFSAT group. Alterations in Ca(2+) transients, L-type Ca(2+) currents, and protein expression of sarco(endo)plasmic reticulum Ca(2+)-ATPase and phosphorylated phospholamban could not account for the changes in the in vivo contractile properties. In conclusion, the cardioprotective effects associated with SAT feeding in HF may occur at the level of the isolated cardiomyocyte, specifically involving changes in myofilament function but not sarcoplasmic reticulum Ca(2+) regulatory properties. |
---|---|
AbstractList | Pathological conditions such as diabetes, insulin resistance, and obesity are characterized by elevated plasma and myocardial lipid levels and have been reported to exacerbate the progression of heart failure (HF). Alterations in cardiomyocyte Ca(2+) regulatory properties and myofilament proteins have also been implicated in contractile dysfunction in HF. However, our prior studies reported that high saturated fat (SAT) feeding improves in vivo myocardial contractile function, thereby exerting a cardioprotective effect in HF. Therefore, we hypothesized that SAT feeding improves contractile function by altering Ca(2+) regulatory properties and myofilament protein expression in HF. Male Wistar rats underwent coronary artery ligation (HF) or sham surgery (SH) and were fed normal chow (SHNC and HFNC groups) or a SAT diet (SHSAT and HFSAT groups) for 8 wk. Contractile properties were measured in vivo [echocardiography and left ventricular (LV) cannulation] and in isolated LV cardiomyocytes. In vivo measures of contractility (peak LV +dP/dt and -dP/dt) were depressed in the HFNC versus SHNC group but improved in the HFSAT group. Isolated cardiomyocytes from both HF groups were hypertrophied and had decreased percent cell shortening and a prolonged time to half-decay of the Ca(2+) transient versus the SH group; however, SAT feeding reduced in vivo myocyte hypertrophy in the HFSAT group only. The peak velocity of cell shortening was reduced in the HFNC group but not the HFSAT group and was positively correlated with in vivo contractile function (peak LV +dP/dt). The HFNC group demonstrated a myosin heavy chain (MHC) isoform switch from fast MHC-α to slow MHC-β, which was prevented in the HFSAT group. Alterations in Ca(2+) transients, L-type Ca(2+) currents, and protein expression of sarco(endo)plasmic reticulum Ca(2+)-ATPase and phosphorylated phospholamban could not account for the changes in the in vivo contractile properties. In conclusion, the cardioprotective effects associated with SAT feeding in HF may occur at the level of the isolated cardiomyocyte, specifically involving changes in myofilament function but not sarcoplasmic reticulum Ca(2+) regulatory properties. |
Author | Cheng, Y McElfresh, T A Chandler, M P Berthiaume, J M Yu, X Castel, L Li, W Chen, X Van Wagoner, D R |
Author_xml | – sequence: 1 givenname: Y surname: Cheng fullname: Cheng, Y organization: Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio 44106-4970, USA – sequence: 2 givenname: W surname: Li fullname: Li, W – sequence: 3 givenname: T A surname: McElfresh fullname: McElfresh, T A – sequence: 4 givenname: X surname: Chen fullname: Chen, X – sequence: 5 givenname: J M surname: Berthiaume fullname: Berthiaume, J M – sequence: 6 givenname: L surname: Castel fullname: Castel, L – sequence: 7 givenname: X surname: Yu fullname: Yu, X – sequence: 8 givenname: D R surname: Van Wagoner fullname: Van Wagoner, D R – sequence: 9 givenname: M P surname: Chandler fullname: Chandler, M P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21765056$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kEtOwzAYhC0Eog84ARLyAZpiO3EfSxTxkiqxgXX12_7duEqcyHFAXXIQLsGSJUfhJKQFViPNSN9oZkSOfe2RkAvOppxLcQXbpkAIccpYlrGpYJwfkWGfiITLdDkgo7bdMsbkfJaekoHg85lkcjYk73kBfoMtdZ5Wu9q6Eir0kTahjuh8O6Gqi9TXkebw9fH99kkDbroSoqv9hEJACm1bawcRDX11saBAC7cpEguRGocxcd50ug9d1TNf8EDvy3TtYwAdXYnUdl7vgXv_MINacGUX8IycWChbPP_TMXm-vXnK75PV491Dfr1KGpGxmKhMgrYppoA2s4pnhpsFm8PSapNyZZcAWhm1WGScM2m05HyWCpMJIZQAycWYXP5ym05VaNZNcBWE3fr_J_EDculyGw |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1152/ajpheart.00440.2011 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1522-1539 |
ExternalDocumentID | 21765056 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: HL-081857 |
GroupedDBID | --- 23M 2WC 39C 3O- 4.4 53G 5GY 5VS 6J9 8M5 AAFWJ ABJNI ACBEA ACIWK ACPRK ADBBV AENEX AFFNX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKKCC BKOMP BTFSW C1A CGR CUY CVF DIK E3Z EBS ECM EIF EJD EMOBN F5P GX1 H13 ITBOX KQ8 NPM OK1 P2P PQQKQ RAP RHF RHI RPL RPRKH TR2 UKR W8F WH7 WOQ XSW YSK YYP ~02 |
ID | FETCH-LOGICAL-p240t-b45acf3e3aef4fb14d1d807a9fcd31bf9aacbdb8841105dc511632d4222b2a512 |
IngestDate | Sat Sep 28 07:49:13 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p240t-b45acf3e3aef4fb14d1d807a9fcd31bf9aacbdb8841105dc511632d4222b2a512 |
OpenAccessLink | https://europepmc.org/articles/pmc3197361 |
PMID | 21765056 |
ParticipantIDs | pubmed_primary_21765056 |
PublicationCentury | 2000 |
PublicationDate | 2011-10-01 |
PublicationDateYYYYMMDD | 2011-10-01 |
PublicationDate_xml | – month: 10 year: 2011 text: 2011-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | American journal of physiology. Heart and circulatory physiology |
PublicationTitleAlternate | Am J Physiol Heart Circ Physiol |
PublicationYear | 2011 |
References | 16093498 - Ann N Y Acad Sci. 2005 Jun;1047:208-18 19039316 - Obesity (Silver Spring). 2009 Feb;17(2):283-9 10666070 - Am J Physiol Heart Circ Physiol. 2000 Feb;278(2):H412-9 19007786 - J Mol Cell Cardiol. 2009 Jan;46(1):39-46 17229941 - Diabetes. 2007 Apr;56(4):1136-42 11056107 - Circulation. 2000 Oct 31;102(18):2284-99 9737516 - Circulation. 1998 Sep 8;98(10):969-76 12181154 - Am J Physiol Heart Circ Physiol. 2002 Sep;283(3):H1225-36 21257760 - J Biol Chem. 2011 Mar 25;286(12):9935-40 12007739 - Trends Cardiovasc Med. 2002 Apr;12(3):134-8 20869969 - J Mol Cell Cardiol. 2011 Jan;50(1):2-5 16173943 - Clin Exp Pharmacol Physiol. 2005 Oct;32(10):825-31 1321440 - Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6452-6 15855227 - FASEB J. 2005 Jul;19(9):1137-9 17601540 - J Am Coll Cardiol. 2007 Jul 3;50(1):22-4 20852054 - Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1917-27 9403622 - Circulation. 1997 Dec 2;96(11):3974-84 9730105 - J Card Fail. 1998 Jun;4(2):121-6 19201998 - Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H1069-79 15765136 - J Clin Invest. 2005 Mar;115(3):547-55 6454511 - Circ Res. 1981 Aug;49(2):525-32 11033110 - Cardiovasc Res. 2000 Oct;48(1):77-88 15475530 - Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H2049-53 14597618 - J Biol Chem. 2004 Feb 6;279(6):4782-93 20086077 - Physiol Rev. 2010 Jan;90(1):207-58 17060511 - Hypertension. 2006 Dec;48(6):1116-23 12734580 - Biol Proced Online. 2001 Dec 11;3:43-53 11164840 - Cardiovasc Res. 2001 Feb 1;49(2):298-307 19023131 - Circ Res. 2009 Jan 2;104(1):95-103 19936093 - Gene Regul Syst Bio. 2007 Nov 05;1:251-62 8572175 - Am J Physiol. 1995 Dec;269(6 Pt 1):C1464-73 2942954 - Physiol Rev. 1986 Jul;66(3):710-71 17656369 - J Biol Chem. 2007 Sep 21;282(38):28063-73 17119150 - Physiology (Bethesda). 2006 Dec;21:380-7 12181432 - Mol Pharmacol. 2002 Sep;62(3):554-65 16416042 - Heart Fail Rev. 2005 Sep;10(3):187-97 19324966 - Circulation. 2009 Apr 14;119(14):e391-479 9737944 - J Mol Cell Cardiol. 1998 Aug;30(8):1581-93 9405163 - J Mol Cell Cardiol. 1997 Nov;29(11):2873-92 9737947 - J Mol Cell Cardiol. 1998 Aug;30(8):1615-30 16013443 - Mol Cell Biochem. 2005 May;273(1-2):87-95 18339649 - Cardiovasc Res. 2008 Jul 15;79(2):331-40 15992646 - J Am Coll Cardiol. 2005 Jul 5;46(1):125-33 16416047 - Heart Fail Rev. 2005 Sep;10(3):249-57 12895480 - Anal Biochem. 2003 Sep 1;320(1):149-51 20511406 - Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H410-21 12840659 - Curr Opin Lipidol. 2003 Jun;14(3):281-7 12065316 - Circ Res. 2002 Jun 14;90(11):1150-2 7614728 - Circ Res. 1995 Aug;77(2):439-44 20201903 - Ann N Y Acad Sci. 2010 Feb;1188:191-8 17166490 - Cardiovasc Res. 2007 Jan 15;73(2):257-68 |
References_xml | |
SSID | ssj0005763 |
Score | 2.155826 |
Snippet | Pathological conditions such as diabetes, insulin resistance, and obesity are characterized by elevated plasma and myocardial lipid levels and have been... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | H1438 |
SubjectTerms | Animals Blotting, Western Body Weight - physiology Calcium - physiology Calcium Channels, L-Type - physiology Calcium Signaling - physiology Coronary Vessels - physiology Diet Dietary Fats - pharmacology Electrocardiography Heart Failure - physiopathology Hemodynamics - physiology Ligation Male Myocardial Contraction - drug effects Myocardium - metabolism Myocardium - pathology Myocytes, Cardiac - drug effects Myocytes, Cardiac - physiology Myofibrils - metabolism Myosin Heavy Chains - metabolism Phosphorylation Rats Rats, Wistar |
Title | Changes in myofilament proteins, but not Ca²⁺ regulation, are associated with a high-fat diet-induced improvement in contractile function in heart failure |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21765056 |
Volume | 301 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF4lICEuCFr-yo_2QLi4LvFPYueYmqAeKEIiSL1Vs95dyahxo9Q59NgH4SU4cuRReBJmZ3dtqyoCDlysaL1ybH-fZmfG384w9ioaa1yYpAg1yDJMp-MsxJkQClwsIRexVkBNbD9lH07yt4t0MRj4Pp_d2H9FGscQa7Nz9h_Qbi-KA_gbMccjoo7Hv8Ldbhcglevq0vTjBvrcT_UYXG5ZbJugPm-CAkZFPDqMSfAQjQ7nwcZ2pq_sp3gjCgMHn1epQ2AKHOM7bwJZqSbEkH5rJAQVJSco1xiQtN0kjdGWnqnALJ1eUmn6ZzeBhurMVTJpK-D6L0e9UhaUdaG0_4HZLrWxYviy2hjtLIkDuhmdTEFZ69W66O-rVkfoE5B6oy4onbTsUrmF26Zy0s-DOCGepaVythvjajTgs75xT9yUqp-6IFN9ZBq_37yITExRWviypndyQF25qdhrfzaivl4RhzComxo_8s9nr1X29qeGbIh-mnHli-NOnoSG31XJwvt5c8PdUB1re4VrMRH5Rsv77J4LavjcsvEBG6h6h-3OawRpdclf848tTDvszrFTc-yyr46rvKp5j6vcc3WfI1M5MpUX8OPbz6vvvOPnPkd28o6d3LCTA_fs5H128h47zZ_12Mk9O804PTt37HzIPr9bLIuj0LULCdfoljahSCdQ6kQloHSqRZTKSObjDGa6lEkk9AygFFLkeYou70SWGGpMk1iaHKiIAR3fR-xWfV6rJ4zHmYnEFYYOcZaqFIOcCITUOcQTCXE-fsoe2_d9urY1YU49Enu_PfOM3e1o-5zd1mhw1As2vJDblwT9L1YXqUg |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+myofilament+proteins%2C+but+not+Ca%C2%B2%E2%81%BA+regulation%2C+are+associated+with+a+high-fat+diet-induced+improvement+in+contractile+function+in+heart+failure&rft.jtitle=American+journal+of+physiology.+Heart+and+circulatory+physiology&rft.au=Cheng%2C+Y&rft.au=Li%2C+W&rft.au=McElfresh%2C+T+A&rft.au=Chen%2C+X&rft.date=2011-10-01&rft.eissn=1522-1539&rft.volume=301&rft.issue=4&rft.spage=H1438&rft_id=info:doi/10.1152%2Fajpheart.00440.2011&rft_id=info%3Apmid%2F21765056&rft_id=info%3Apmid%2F21765056&rft.externalDocID=21765056 |